Clinical trials
Observational Cardiomyopathy, Hypertrophic trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 6 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 32 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Xijing Hospital | 4 |
| Beijing Institute of Heart, Lung and Blood Vessel Diseases | 2 |
| Heidelberg University | 2 |
| Ajou University School of Medicine | 1 |
| Amsterdam UMC, location VUmc | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Atlantic Health System | 1 |
| Brigham and Women's Hospital | 1 |
| Centro Cardiologico Monzino | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiomyopathy, Hypertrophic | 32 |
| Cardiomyopathy, Dilated | 6 |
| Arrhythmogenic Right Ventricular Dysplasia | 4 |
| Cardiomyopathy, Restrictive | 3 |
| Hypertrophy, Left Ventricular | 3 |
| Fabry Disease | 2 |
| Heart Failure | 2 |
| Postoperative Complications | 2 |
| Amyloid Neuropathies, Familial | 1 |
| Amyloidosis | 1 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.